Effects of adenosine A1 and A2A receptor activation on the evoked release of glutamate from rat cerebrocortical synaptosomes
Open Access
- 1 June 2002
- journal article
- Published by Wiley in British Journal of Pharmacology
- Vol. 136 (3), 434-440
- https://doi.org/10.1038/sj.bjp.0704712
Abstract
The effects of adenosine A2A and A1 receptor activation on the release of glutamate were studied in rat cerebral cortex synaptosomes exposed in superfusion to adenosine receptor ligands. Adenosine (0.1 μM) produced a significant potentiation of the Ca2+‐dependent K+(15 mM)‐evoked [3H]‐D‐aspartate overflow (20.4±3.5%), which was blocked by A2A blocker SCH58261 (0.1 μM). At higher concentrations (10 – 1000 μM) adenosine inhibited in a DPCPX‐sensitive manner the Ca2+‐dependent K+‐evoked [3H]‐D‐aspartate overflow. The inhibitory effect of adenosine at 1000 μM was significantly increased by SCH58261. This inhibition was antagonized by 1 μM DPCPX. Adenosine did not produce any effect on basal release. The A2A receptor agonist CGS 21680 was ineffective on basal release, but stimulated the Ca2+‐dependent K+‐evoked overflow of [3H]‐D‐aspartate (EC50 ≃ 1 pM). The effect of 0.01 nM CGS 21680 was totally sensitive to the A2A receptor antagonist SCH58261 (IC50 ≃5 nM). The A1 receptor agonist CCPA inhibited the Ca2+‐dependent K+‐evoked [3H]‐D‐aspartate overflow (EC50 ≃ 20 nM). The effect of 100 nM CCPA was abolished by 100 nM of the A1 receptor antagonist DPCPX. The K+(15 mM)‐evoked overflow of endogenous glutamate was enhanced by CGS 21680 (0.01 nM) and inhibited by CCPA (0.1 μM). The effect of CGS 21680 was abolished by SCH58261 (0.1 μM) and that of CCPA by DPCPX (0.1 μM). It is concluded that adenosine and adenosine receptor agonists modulate glutamate release by activating inhibitory A1 and excitatory A2A receptors present on glutamatergic terminals of the rat cerebral cortex. British Journal of Pharmacology (2002) 136, 434–440; doi:10.1038/sj.bjp.0704712Keywords
This publication has 41 references indexed in Scilit:
- Effect of γ-butyrobetaine on fatty liver in juvenile visceral steatosis miceJournal of Pharmacy and Pharmacology, 2001
- The effect of nucleotides and adenosine on stimulus‐evoked glutamate release from rat brain cortical slicesBritish Journal of Pharmacology, 2000
- Purinergic modulation of [3H]GABA release from rat hippocampal nerve terminalsNeuropharmacology, 2000
- CGS 15943, An adenosine A2 receptor antagonist, reduces cerebral ischemic injury in the mongolian gerbilLife Sciences, 1994
- Purinergic Modulation of the Evoked Release of [3H]Acetylcholine from the Hippocampus and Cerebral Cortex of the Rat: Role of the EctonucleotidasesEuropean Journal of Neuroscience, 1994
- Adenosine A1 Receptor Inhibition of Glutamate Exocytosis and Protein Kinase C‐Mediated DecouplingJournal of Neurochemistry, 1993
- Excitatory Transmitter Amino Acid Release from the Ischemic Rat Cerebral Cortex: Effects of Adenosine Receptor Agonists and AntagonistsJournal of Neurochemistry, 1992
- The selective A2 adenosine receptor agonist CGS 21680 enhances excitatory transmitter amino acid release from the ischemic rat cerebral cortexNeuroscience Letters, 1992
- Excitatory and inhibitory effects of adenosine on the neurotransmission in the hippocampal slices of guinea pigBrain Research, 1990
- A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye bindingAnalytical Biochemistry, 1976